Viewing Study NCT02013856


Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-02-23 @ 12:22 PM
Study NCT ID: NCT02013856
Status: COMPLETED
Last Update Posted: 2016-12-02
First Post: 2013-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk (FLAVASCULAR Study)
Sponsor: Quadram Institute Bioscience
Organization:

Study Overview

Official Title: The Effects of Apple Derived Flavanols on Cardiovascular Disease Risk
Status: COMPLETED
Status Verified Date: 2015-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FLAVASCULAR
Brief Summary: Fruit and vegetable rich diets are associated with a reduced risk of cardiovascular disease (CVD). The protective effect may be ascribed to compounds contained within these foods, called flavonoids. Flavanols (epicatechin and procyanidins) are a particular group of flavonoids and are found mostly in apples, berry fruits, dark chocolate, tea and red wine. There is evidence to suggest that ingestion of flavanol rich foods and beverages beneficially alter 'markers' of CVD risk (e.g. blood pressure). The aim of this study is to determine the acute and chronic effects of apple derived flavanols on some risk markers for CVD.
Detailed Description: This study is a single arm randomized, 4-phase crossover design.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: